Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 311,827,392
  • Shares Outstanding, K 2,735,880
  • Annual Sales, $ 70,074 M
  • Annual Income, $ 15,409 M
  • 36-Month Beta 0.72
  • Price/Sales 4.36
  • Price/Book 4.31

Price Performance

See More
Period Period Low Period High Performance
1-Month
113.37 +1.08%
on 01/12/17
117.30 -2.30%
on 12/14/16
-1.29 (-1.11%)
since 12/13/16
3-Month
109.32 +4.83%
on 12/07/16
122.50 -6.45%
on 11/09/16
-3.66 (-3.09%)
since 10/13/16
52-Week
94.28 +21.55%
on 01/21/16
126.07 -9.10%
on 07/20/16
+17.58 (+18.12%)
since 01/13/16

Most Recent Stories

More News
Biotechnology/Pharmaceutical Services Outsourcing Market Analysis 2014 - 2025 - Research and Markets

Research and Markets has announced the addition of the "Biotechnology/Pharmaceutical Services Outsourcing Market Analysis, By Service And Segment Forecasts, 2014 - 2025" report to their offering....

Trump Attacks Biotech & Pharma: ETFs Bleed

Trump pledged to initiate a bidding process for drug cost that shed roughly $24.6 billion in 20 minutes from the nine biggest pharmaceutical companies by market cap.

Johnson & Johnson Becomes #13 Most Shorted Dow Stock, Replacing DuPont

The most recent short interest data has been released for the 12/30/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the...

Trump Attacks Biotech & Pharma: ETFs Bleed

Trump pledged to initiate a bidding process for drug cost that shed roughly $24.6 billion in 20 minutes from the nine biggest pharmaceutical companies by market cap.

Stock Market Roundup Jan. 11: Health Sector Lower on Trump "Murder" Comment

After President-elect Donald Trump said pharmaceutical companies were ???getting away with murder,??? in how much they charge the government for medicines.

Correction: Drug Prices-Johnson & Johnson story

In a story Jan. 10 about Johnson & Johnson's plans to disclose some information on its prescription drug price increases, The Associated Press reported erroneously the use of the company's drug Xarelto....

Startup Competition Puts Purpose Into Profit

Today, Circular Board announced its upcoming Pitch with Purpose, a pitch competition for women entrepreneurs leading high-growth, scalable businesses that support the resolution of the world's most pressing...

Novo Nordisk (NVO) Fiasp Gets EU Nod for Diabetes in Adults

Novo Nordisk (NVO) announced that its fast-acting insulin aspart, Fiasp, has been approved in the EU for the treatment of diabetes in adults.

Business Highlights

___

5 ETF Investment Ideas for 2017

We have highlighted some ETF areas that are likely to shine in 2017.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Support & Resistance

2nd Resistance Point 115.27
1st Resistance Point 114.93
Last Price 114.60
1st Support Level 114.35
2nd Support Level 114.11

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.